SALES of pet identification products have been better than expected after investing in new database, York business Animalcare has said.

The business, based at Dunnington, said in a pre-close trading update ahead of the publication of its results for the year to June 30, that revenue from its pet identification products would be slightly better than indicated in May, but still about 29 per cent below 2011.

Its core business of selling generic veterinary medicines is about 17 per cent up on last year, excluding the impact of a temporary disruption to the supply of one of its painkiller products, Buprecare ampoules. With this taken into account, sales for the segment were about 2 per cent ahead of last year.

In May, when the business warned of reduced profits, Stephen Wildridge, chief executive, said it continued to recruit new staff to its 53-strong team and that they expected growth across the business, following the investment in the pet identification side of the business and new product launches in its veterinary medicines business.